Related Experiment Video
Updated: Jun 16, 2026
09:11
A Comparative Analysis of Recombinant Protein Expression in Different Biofactories: Bacteria, Insect Cells and Plant Systems
Published on: March 23, 2015
24.8K
Achieving Glycemic Targets in and out-of-School: Real-World Data From 1341 Italian Children Using the MiniMed 780G
Jen McVean1, Riccardo Schiaffini2, Marta Bassi3,4
1Diabetes Operating Unit, Medtronic, Tolochenaz, Switzerland.
Pediatric Diabetes
|April 10, 2026
Summary
The MiniMed 780G system effectively manages blood sugar in children with type 1 diabetes (T1D) during school and out-of-school days. This ensures optimal glycemic control, supporting cognitive development and learning.
Area of Science:
- Pediatric Endocrinology
- Diabetes Technology
- Metabolic Health
Background:
- Type 1 diabetes (T1D) management in children requires consistent glycemic control.
- The MiniMed 780G system with auto mode offers advanced automated insulin delivery.
- Understanding system performance during different daily routines is crucial for optimizing T1D care.
Purpose of the Study:
- To evaluate glycemia and insulin delivery in Italian children with T1D using the MiniMed 780G system in auto mode.
- To compare system performance between school days and out-of-school (OOS) days.
- To assess the impact of daily routines on glycemic control in pediatric T1D patients.
Main Methods:
- Real-world analysis of 1341 Italian children under 16 with T1D using the MiniMed 780G system.
- Comparison of time in range (TIR) and glucose variability on school days versus OOS days.
- Analysis of sensor glucose data and insulin delivery patterns.
Main Results:
- No significant difference in TIR between school days (73.4%) and OOS days (72.4%).
- International glycemic targets were met on average on both types of days.
- Minor glucose variations (post-breakfast peak, pre-lunch dip) were effectively managed by the insulin delivery algorithm during school hours.
Conclusions:
- The MiniMed 780G system in auto mode provides consistent glycemic control for children with T1D, irrespective of school routines.
- Effective management of glycemia during school days supports cognitive function and brain development.
- Automated insulin delivery systems can help maintain optimized glucose levels, facilitating daily activities and long-term health in pediatric T1D.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...